Anzeige
Mehr »
Mittwoch, 25.03.2026 - Börsentäglich über 12.000 News
+2.000% bisher - kommt jetzt der nächste Antimon-Trade? A2 Gold zündet die nächste Stufe!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PVB0 | ISIN: CA9255401064 | Ticker-Symbol: VV5
Frankfurt
25.03.26 | 08:12
0,136 Euro
+1,49 % +0,002
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
VEXT SCIENCE INC Chart 1 Jahr
5-Tage-Chart
VEXT SCIENCE INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,1360,15509:01

Aktuelle News zur VEXT SCIENCE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
04.03.Vext Science Inc: Vext receives licence for seventh dispensary in Ohio4
03.03.VEXT Science, Inc.: Vext Advances Ohio Expansion with Seventh Retail Location384Secures provisional dual-use license for Columbus dispensary, with operations expected to begin in Q4 2026, subject to regulatory approvals.Marks Vext's seventh dispensary in Ohio, and second in...
► Artikel lesen
02.01.Vext Science Inc: Vext Science investor Nguyen sells 20,340 shares8
11.12.25VEXT Science, Inc.: Vext Announces Voting Results of Annual General Meeting429Vancouver, British Columbia--(Newsfile Corp. - December 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("VEXT" or the "Company"), a U.S.-based cannabis operator with vertical operations...
► Artikel lesen
20.11.25VEXT Science, Inc.: Vext Reports Q3 2025 Financial Results1.073Vext Reports Q3 2025 Financial Results; Revenue Up 41% Year-over-Year and Operating Cash Flow Year-To-Date Reaches $8.5 Million Revenue of $12.7 million, up 41% YoY, driven by expanded Ohio retail operations...
► Artikel lesen
20.11.25Vext Science Inc: Vext Science has EBITDA of $2.31M (U.S.) in Q3 20254
20.11.25Vext Science reports Q3 results4
VEXT SCIENCE Aktie jetzt für 0€ handeln
11.11.25Vext Science Inc: Vext Science to release Q3 2025 results Nov. 201
11.11.25VEXT Science, Inc.: Vext to Announce Financial Results for Q3 2025 on November 20, 2025387Vancouver, British Columbia--(Newsfile Corp. - November 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations...
► Artikel lesen
17.09.25VEXT Science, Inc.: Vext Secures State Approval for Portsmouth Dispensary Ownership Transfer387Upon closing, expected by October 1, 2025, Portsmouth will become Vext's fifth fully consolidated dispensary in Ohio. The Company expects to bring additional locations online through late 2025 and...
► Artikel lesen
20.08.25VEXT Science, Inc.: Vext Announces Q2 2025 Financial Results: Record Quarterly Revenue with Strong 31% Cash Flow Margin565Record financial performance, with growth in revenue, adjusted EBITDA, and operating cash flow driven by strong Ohio momentum and disciplined operations in Arizona.Revenue of $13.4 million, up 59%...
► Artikel lesen
11.08.25VEXT Science, Inc.: Vext to Announce Financial Results for Q2 2025 on August 20, 2025365Vancouver, British Columbia--(Newsfile Corp. - August 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in...
► Artikel lesen
24.06.25VEXT Science, Inc.: Vext Continues Ohio Expansion with Sixth Dispensary Location in Fairfield393Secures a provisional license for sixth Ohio dispensary in Fairfield, with operations expected to begin in Q4 2025, subject to regulatory approvals.Demonstrates Vext's strategic approach to retail...
► Artikel lesen
16.06.25VEXT Science, Inc.: Vext Opens Fifth Ohio Dispensary in Portsmouth, Growing Retail Footprint in Key Ohio Market387Vancouver, British Columbia--(Newsfile Corp. - June 16, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with vertical operations in Arizona...
► Artikel lesen
05.06.25VEXT Science, Inc.: Vext Announces Change of Auditor642Vancouver, British Columbia--(Newsfile Corp. - June 5, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona...
► Artikel lesen
21.05.25VEXT Science, Inc.: Vext Delivers Record Q1 Performance: Achieves $3.1 Million in Operating Cash Flow on $11.6 Million in Revenue521Revenue grew 38% to $11.6 million compared to $8.4 million in Q1 2024, and up 13% sequentially from $10.2 million in Q4 2024, driven by growth in Ohio.Q1 2025 operating cash flow reached $3.1 million...
► Artikel lesen
13.05.25VEXT Science, Inc.: Vext to Announce Financial Results for Q1 2025 on May 21, 2025450Vancouver, British Columbia--(Newsfile Corp. - May 13, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona...
► Artikel lesen
04.04.25VEXT Science, Inc.: Vext Strengthens Balance Sheet and Sharpens Focus on Core Markets with Strategic Sale of Kentucky Medical Processing License560Vancouver, British Columbia--(Newsfile Corp. - April 4, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertically integrated operations...
► Artikel lesen
03.04.25VEXT Science, Inc.: Vext Completes Ohio Expansion Transaction, Expanding Ohio Retail Presence to Four Dispensaries532Vext now operates four retail dispensaries in Ohio's limited license market and remains on track to reach the state license cap of eight (8) total dispensaries, with new locations expected to open...
► Artikel lesen
31.03.25VEXT Science, Inc.: Vext Delivers Solid Q4 Financial Results - Turning Point as Ohio Operations Gain Momentum327Q4 2024 marked Vext's strongest operating quarter in recent years, with growth across revenue, adjusted EBITDA, and cash flow.Revenue of $10.2 million in Q4 2024 (+13% QoQ), driven by Ohio adult-use...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1